Dermatology

Funds UK or Republic of Ireland based research, which will benefit patients with skin disease and will benefit dermatological research in the future.

Funds pioneering research that advances the discovery of new medicines.

Funds tenured and non-tenured researchers, clinicians and non-clinicians to undertake high quality biomedical research and has no priority diseases or restrictions on the research area supported.

Aim is to find a suitable long-lasting treatment or cure for Hidradenitis Suppurativa. Preference is given to those wishing to look further into their Top 10 Research Priorities.

Funds UK or Republic of Ireland based research, which will benefit patients with skin disease and will benefit dermatological research in the future.

This will study incidence, early management and outcomes of babies born with Harlequin ichthyosis (HI) or collodion membrane (CM). These are rare genetic conditions characterised by thick, tight scaly skin and significant neonatal mortality.

This two year, prospective BPSU study investigates the incidence, early management and outcomes at 12 months, of babies born with harlequin ichthyosis (HI) or collodion membrane (CM) born between 1 November 2018 and 31 October 2020. These are rare genetic conditions characterised by thick, tight sca...

Child Protection Evidence is a resource available for clinicians across the UK and internationally to inform clinical practice, child protection procedures and professional and expert opinion in the legal system. This systematic review evaluates the literature on abusive and non-abusive burns.

Provides five years of funding to enable talented clinicians to pursue academic research alongside their clinical practice.

Provides five years of funding to enable talented clinicians to pursue academic research alongside their clinical practice.